treatment of cerebral glioblastoma-caused bruxism with mirtazapine: a case report
Clicks: 348
ID: 162529
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
348 views
42 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #1 of 4 articles by views in journal of archaeological research
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Background Bruxism refers to grind or gnash the opposing rows of upper and lower molar teeth. It is important to treat bruxism as a factor that can influence sleep quality, quality of life, and mental status in patients with malignancy. Case presentation A 41-year-old male developed bruxism secondary to cerebral glioblastoma. l-dopa, gabapentin, clonazepam, clonidine, baclofen, buspirone, or propranolol were not effective. Mirtazapine, prescribed for side effects of chemotherapy, was effective for bruxism, which was disappeared within 3 weeks. Conclusions Mirtazapine was effective for treating bruxism as well as chemotherapy complications.
| Reference Key |
khosravi2020jatreatment
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Mohsen Khosravi |
| Journal | journal of archaeological research |
| Year | 2020 |
| DOI |
10.1186/s40981-020-00329-4
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.